Bromocriptine methanesulfonate
- Level
- Commodity
- Parent
- 51142500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51142547This classification denotes a neuroprotective agent with the molecular formula C32H40BrN5O5.CH4O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FFP983J3OD, chemically known as ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, monomethanesulfonate (salt), (5'.alpha.)-, but more generally known as bromocriptine methanesulfonate, which bears US NIH Compound Identifier 31100. European Medicines Agency schedules bromocriptine methanesulfonate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05918MIG. Most nations, for tariff purposes, schedule bromocriptine methanesulfonate under HS 29396900. SMILES: CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@H]4CN([C@@H]5CC6C7C(CCCC7[NH]C6BR)C5=C4)C)O.CS(=O)(=O)O.
Same parent
Under 51142500 · 69Activities that produce or sell this
KBLI · 8Inherited from family 51140000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.